This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Certainly! Here is the article about inventor Suk Kyeong Jung:
Title: Inventor Spotlight: Suk Kyeong Jung
Introduction:
Suk Kyeong Jung is a talented inventor based in Taejeon-si, South Korea, with a passion for developing innovative pharmaceutical solutions. With a keen focus on rhodanine derivatives and their potential in treating various diseases, Jung has made significant contributions to the field of biotechnology.
Latest Patents:
Jung holds a groundbreaking patent titled "Rhodanine derivatives, a process for the preparation thereof, and pharmaceutical composition containing the same." This patent unveils rhodanine derivatives with potent inhibitory activity against protein phosphatases such as PTP1B, Prl-3, LAR, CD45, Cdc25A, Cdc25B, Cdc25C, Yop, PP1, and VHR. These derivatives offer promising prospects for combating diseases like autoimmune diseases, diabetes, obesity, and certain types of cancers.
Career Highlights:
Suk Kyeong Jung is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he channels his expertise into pioneering research and development. His dedication to advancing the pharmaceutical landscape through cutting-edge innovations has garnered recognition within the industry.
Collaborations:
In his professional journey, Jung has collaborated with esteemed colleagues such as Seong Eon Ryu and Seung Jun Kim. Together, they have synergized their skills and knowledge to propel forward-thinking projects aimed at addressing unmet medical needs and improving patient outcomes.
Conclusion:
In conclusion, Suk Kyeong Jung stands as a prominent figure in the realm of pharmaceutical innovation, with a singular focus on leveraging rhodanine derivatives for therapeutic purposes. His relentless pursuit of novel solutions and strategic collaborations underscore his commitment to making a lasting impact on healthcare. Jung's patent represents a significant milestone in the field, paving the way for future breakthroughs in disease treatment and management.
I hope you find this article insightful and informative! If you have any more requests or need further assistance, feel free to ask.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile